Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

被引:36
作者
Asola, R.
Huhtala, H.
Holli, K.
机构
[1] Cent Hosp Satakunta, Dept Oncol, FIN-28500 Pori, Finland
[2] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
[3] Univ Tampere, Sch Med, Tampere, Finland
[4] Univ Hosp, Dept Palliat Med, Tampere, Finland
关键词
end of life; breast cancer; diagnostic; treatment activities;
D O I
10.1007/s10549-006-9224-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the intensity of diagnostic testing and cancer treatment of 335 women with advanced breast cancer during their last 6 months before death between 1995 and 1998 in the Pirkanmaa and Satakunta health care districts and to compare it to the practice in earlier decades, the 1970s and 1980s. Data for 1990s material were collected from medical records in 30-day periods starting from the patient's death backwards. In this material 46.9% of all laboratory tests and 40% of radiological tests during the last 6 months of life were made during the last 2 months prior to death. In the last month 63.9% of patients continued on endocrine therapy and 19.7% on chemotherapy. Patient symptoms and deterioration in general condition showed the appropriate point to discontinue cancer-related treatment and concentrate on palliation of symptoms to be about 2 months prior to death. Resources devoted to diagnostic investigations and treatment of cancer in terminally ill patients could be better used for their care. This would be more likely to improve patients' quality of life and save resources.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 9 条
[1]   Survival of Medicare patients after enrollment in hospice programs [J].
Christakis, NA ;
Escarce, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :172-178
[2]   Impact of individual and market factors on the timing of initiation of hospice terminal care [J].
Christakis, NA ;
Iwashyna, TJ .
MEDICAL CARE, 2000, 38 (05) :528-541
[3]   Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study [J].
Christakis, NA ;
Lamont, EB .
BRITISH MEDICAL JOURNAL, 2000, 320 (7233) :469-472
[4]   Chemotherapy use among medicare beneficiaries at the end of life [J].
Emanuel, EJ ;
Young-Xu, Y ;
Levinsky, NG ;
Gazelle, G ;
Saynina, O ;
Ash, AS .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (08) :639-643
[5]   TERMINAL STAGES OF BREAST-CANCER - CHANGES IN CLINICAL-PRACTICE [J].
HOLLI, K ;
HAKAMA, M .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (10) :1338-1339
[6]   TREATMENT OF THE TERMINAL STAGES OF BREAST-CANCER [J].
HOLLI, K ;
HAKAMA, M .
BRITISH MEDICAL JOURNAL, 1989, 298 (6665) :13-14
[7]   Physician factors in the timing of cancer patient referral to hospice palliative care [J].
Lamont, EB ;
Christakis, NA .
CANCER, 2002, 94 (10) :2733-2737
[8]   Patterns of functional decline at the end of life [J].
Lunney, JR ;
Lynn, J ;
Foley, DJ ;
Lipson, S ;
Guralnik, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (18) :2387-2392
[9]  
Payne SK, 2002, ONCOLOGY-NY, V16, P801